EUVIMEDEUVIMED entdecken
Crossref

Prevalence of long-term complications of COVID-19 infection in patients with underlying disease

Ezatollah Rahimi, Anvar Mohamadi, Hana Khosravi, Nasrin Moghimi

Chronic Diseases Journal · 2024-03 · 12 (2) · 130-139

DOI: 10.22122/cdj.v12i2.895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chronic Diseases Journal, 2024-03. Verfasst von Ezatollah Rahimi und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a health problem worldwide. As our current knowledge about the interaction of various underlying diseases and their management in COVID-19 mortality is gradually evolving, the current study investigated the complications and outcomes of COVID-19 up to 1 year after infection in individuals with underlying diseases. METHODS: In a retrospective cohort study, 725 patients with COVID-19 (414 women and 311 men) who had a history of specific diseases were selected and included in the study. The medical records of COVID-19 patients admitted to Kowsar Hospital, Iran, with cancer, kidney disease, history of organ transplant, history of cerebrovascular accident ‎(CVA), and rheumatic diseases between 2020 and 2021 were investigated. In order to collect information about the condition of the patients and the complications, the patients were contacted until 1 year after contracting COVID-19. For analytical purposes and hypotheses, the chi-square t-test and analysis of variance (ANOVA) were used. Data analysis was performed in Stata software. RESULTS: The most common underlying diseases among hospitalized patients were rheumatic diseases (28.3%), followed by cancer (25.5%), and a history of CVA (16.6%). Despite the treatment, 241 patients (33.2%) died, and 96 of them (13%) died after being discharged from the hospital. CONCLUSION: The results of the present study showed that a decrease in appetite and an increase in the duration of hospitalization can be predictors of the probability of death after COVID-19 infection in patients with a history of the studied underlying diseases.

Schlagwörter

covid-19long-term complicationsrheumatic diseases

Zitieren

APA

Rahimi, E., Mohamadi, A., Khosravi, H., & Moghimi, N. (2024). Prevalence of long-term complications of COVID-19 infection in patients with underlying disease. Chronic Diseases Journal, 12(2), 130-139. https://doi.org/10.22122/cdj.v12i2.895

Vancouver

Rahimi E, Mohamadi A, Khosravi H, Moghimi N. Prevalence of long-term complications of COVID-19 infection in patients with underlying disease. Chronic Diseases Journal. 2024;12(2):130-139. doi:10.22122/cdj.v12i2.895

BibTeX
@article{Rahimi2024,
  author = {Rahimi, Ezatollah and Mohamadi, Anvar and Khosravi, Hana and Moghimi, Nasrin},
  title = {Prevalence of long-term complications of COVID-19 infection in patients with underlying disease},
  journal = {Chronic Diseases Journal},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {130--139},
  doi = {10.22122/cdj.v12i2.895}
}
Kostenlos starten →